Quantcast

Latest Glenmark Pharmaceuticals S.A. Stories

2014-08-20 08:27:31

MUMBAI, August 20, 2014 /PRNewswire/ -- Glenmark Pharmaceuticals S.A.

2014-07-03 08:23:49

MUMBAI,India, July 3, 2014 /PRNewswire/ -- - GBR 830 is an antagonistic monoclonal antibody with first in class potential for the treatment of

2011-03-31 07:27:00

- Glenmark's first novel molecule for an oncology indication - GBR 401 is a monoclonal antibody targeting CD19.


Word of the Day
lahar
  • A volcanic mudflow.
The word 'lahar' comes from Javanese.
Related